Reduced orexin-a levels in frontotemporal dementia: Possible association with sleep disturbance

American Journal of Alzheimer's Disease and other Dementias

Volumn 28, Issue 6, 2013, Pages 606-611

  Çoban, Arzu ^a   Bilgiç, Başar ^a   Lohmann, Ebba ^a   Küçükali, Cem I ^b   Benbir, Gülçin ^c   Karadeniz, Derya ^c   Hanagasi, Hasmet A ^a   Tüzün, Erdem ^b   Gürvit, Hakan ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Department of Neuroscience   (United States)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

frontotemporal dementia; orexin A; plasma; polysomnography; sleep disturbances

Indexed keywords

CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA; CARBIDOPA PLUS LEVODOPA; DONEPEZIL; GALANTAMINE; MEMANTINE; OREXIN A; RIVASTIGMINE;

ADULT; AGED; AGGRESSION; AGITATION; ANEMIA; ANXIETY; APATHY; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DELUSION; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EUPHORIA; FEMALE; FRONTOTEMPORAL DEMENTIA; HALLUCINATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOTHALAMUS; IRRITABILITY; LOCOMOTION; MALE; MULTIPLE SLEEP LATENCY TEST; NARCOLEPSY; PARKINSONISM; POLYSOMNOGRAPHY; PROTEIN BLOOD LEVEL; REM SLEEP; SLEEP DISORDER; SLEEP QUALITY; SLEEP TIME;

FRONTOTEMPORAL DEMENTIA; OREXIN-A; PLASMA; POLYSOMNOGRAPHY; SLEEP DISTURBANCES;

ADULT; AGED; AGED, 80 AND OVER; ATROPHY; CEREBRAL CORTEX; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMANS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NEUROPEPTIDES; POLYSOMNOGRAPHY; SLEEP DISORDERS; SLEEP, REM;

EID: 84883362178     PISSN: 15333175     EISSN: 19382731     Source Type: Journal    
DOI: 10.1177/1533317513494453     Document Type: Article

References (48)

1. Merlino G, Piani A, Gigli GL, et al. Daytime sleepiness is associated with dementia and cognitive decline in older Italian adults: a population-based study. Sleep Med. 2010 ; 11 (4). 372-377
2. Foley D, Monjan A, Masaki K, et al. Daytime sleepiness is associated with 3-year incident dementia and cognitive decline in older Japanese-American men. J Am Geriatr Soc. 2001 ; 49 (12). 1628-1632 (Pubitemid 34007988)
3. Wennström M, Londos E, Minthon L, Nielsen HM. Altered CSF orexin and α-synuclein levels in dementia patients. J Alzheimers Dis. 2012 ; 29 (1). 125-132
4. Baumann CR, Dauvilliers Y, Mignot E, Bassetti CL. Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness. Eur Neurol. 2004 ; 52 (2). 73-76 (Pubitemid 39274286)
5. Friedman LF, Zeitzer JM, Lin L, et al. In Alzheimer disease, increased wake fragmentation found in those with lower hypocretin-1. Neurology. 2007 ; 68 (10). 793-794 (Pubitemid 46667913)
6. Fronczek R, van Geest S, Frölich M, et al. Hypocretin (orexin) loss in Alzheimer's disease. Neurobiol Aging. 2012 ; 33 (8). 1642-1650
7. Martinez-Rodriguez JE, Seppi K, Cardozo A, et al. SINBAR (Sleep Innsbruck Barcelona) group. Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy.. Mov Disord.. 2007 ; 22 (12). 1822-1824 (Pubitemid 47597614)
8. Anderson KN, Hatfield C, Kipps C, Hastings M, Hodges JR. Disrupted sleep and circadian patterns in frontotemporal dementia. Eur J Neurol. 2009 ; 16 (3). 317-323
9. Harper DG, Stopa EG, McKee AC, et al. Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration. Arch Gen Psychiatry. 2001 ; 58 (4). 353-360 (Pubitemid 32303191)
10. Liu W, Miller BL, Kramer JH, et al. Behavioral disorders in the frontal and temporal variants of frontotemporal dementia. Neurology. 2004 ; 62 (5). 742-748 (Pubitemid 38298950)
11. Bathgate D, Snowden JS, Varma A, Blackshaw A, Neary D.. Behaviour in frontotemporal dementia, Alzheimer's disease and vascular dementia. Acta Neurol Scand. 2001 ; 103 (6). 367-378 (Pubitemid 32531137)
12. Compta Y, Santamaria J, Ratti L, et al. Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia. Brain. 2009 ; 132 (pt 12). 3308-3317
13. Poryazova R, Benninger D, Waldvogel D, Bassetti CL. Excessive daytime sleepiness in Parkinson's disease: characteristics and determinants. Eur Neurol. 2010 ; 63 (3). 129-135
14. Baumann C, Ferini-Strambi L, Waldvogel D, Werth E, Bassetti CL. Parkinsonism with excessive daytime sleepiness e a narcolepsy-like disorder?. J Neurol. 2005 ; 252 (2). 139-145 (Pubitemid 40385585)
15. Arnulf I, Konofal E, Merino-Andreu M, et al. Parkinson's disease and sleepiness: an integral part of PD. Neurology. 2002 ; 58 (7). 1019-1024 (Pubitemid 34298539)
16. Overeem S, van Hilten JJ, Ripley B, Mignot E, Nishino S, Lammers GJ. Normal hypocretin-1 levels in Parkinson's disease patients with excessive daytime sleepiness. Neurology. 2002 ; 58 (3). 498-499 (Pubitemid 34150937)
17. Maeda T, Nagata K, Kondo H, Kanbayashi T. Parkinson's disease comorbid with narcolepsy presenting low CSF hypocretin/orexin level. Sleep Med. 2006 ; 7 (8). 662 (Pubitemid 44804240)
18. Kundermann B, Thum A, Rocamora R, Haag A, Krieg JC, Hemmeter U. Comparison of polysomnographic variables and their relationship to cognitive impairment in patients with Alzheimer's disease and frontotemporal dementia. J Psychiatr Res. 2011 ; 45 (12). 1585-1592
19. Kanbayashi T, Sagawa Y, Takemura F, et al. The pathophysiologic basis of secondary narcolepsy and hypersomnia. Curr Neurol Neurosci Rep. 2011 ; 11 (2). 235-241
20. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol. 2002 ; 59 (10). 1553-1562
21. Nishino S, Kanbayashi T. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev. 2005 ; 9 (4). 269-310 (Pubitemid 40982498)
22. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry. 1994 ; 57 (4). 416-418
23. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998 ; 51 (6). 1546-1554
24. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol. 1992 ; 32 (suppl). 125-127
25. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988 ; 51 (6). 745-752
26. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 ; 34 (7). 939-944 (Pubitemid 14076461)
27. Folstein MF, Folstein SE, McHugh PR. ''Mini-mental state''. A practical method for grading the cognitive state of patients for the clinician.. J Psychiatr Res.. 1975 ; 12 (3). 189-198
28. Morris J. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993 ; 43 (11). 2412-2414 (Pubitemid 23346995)
29. Reisberg B, Ferris SH, de Leon MJ, Crook T. Global Deterioration Scale (GDS). Psychopharmacol Bull. 1988 ; 24 (4). 661-663
30. Cummings JL.. The neuropsychiatric inventory. Assessing psychopathology in dementia patients. Neurology. 1997 ; 48 (5 suppl 6). S10 - S16
31. Johns MW. Sleepiness in different situations measured by the Epworth Sleepiness Scale. Sleep. 1994 ; 17 (8). 703-710
32. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index (PSQI): a new instrument for psychiatric research and practice. Psychiatry Res. 1989 ; 28 (2). 193-213 (Pubitemid 19144991)
33. Zucconi M, Ferri R, Allen R, et al. The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG).. Sleep Med.. 2006 ; 7 (2). 175-183
34. Nakamura M, Kanbayashi T, Sugiura T, Inoue Y. Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels. J Sleep Res. 2011 ; 20 (1 pt 1). 45-49
35. Ebrahim IO, Sharief MK, de Lacy S, et al. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia. J Neurol Neurosurg Psychiatry. 2003 ; 74 (1). 127-130 (Pubitemid 36069052)
36. Bassetti C, Gugger M, Bischof M, et al. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A). Sleep Med. 2003 ; 4 (1). 7-12 (Pubitemid 36284870)
37. Baumann CR, Khatami R, Werth E, Bassetti CL. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy. J Neurol Neurosurg Psychiatry. 2006 ; 77 (3). 402-404
38. Terzano MG, Smerieri A, Del Felice A, et al. Cyclic alternating pattern (CAP) alterations in narcolepsy. Sleep Med. 2006 ; 7 (8). 619-626 (Pubitemid 44804235)
39. Frauscher B, Gschliesser V, Brandauer E, et al. Motor disturbances during non-REM and REM sleep in narcolepsy-cataplexy: a video-polysomnographic analysis. J Sleep Res. 2011 ; 20 (4). 514-521
40. Yasui K, Inoue Y, Kanbayashi T, Nomura T, Kusumi M, Nakashima K. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration. J Neurol Sci. 2006 ; 250 (1-2). 120-123 (Pubitemid 44665944)
41. Abdo WF, Bloem BR, Kremer HP, Lammers GJ, Verbeek MM, Overeem S. CSF hypocretin-1 levels are normal in multiple-system atrophy. Parkinsonism Relat Disord. 2008 ; 14 (4). 342-344 (Pubitemid 351735999)
42. Drouot X, Moutereau S, Nguyen JP, et al. Low levels of ventricular CSF orexin/hypocretin in advanced PD. Neurology. 2003 ; 61 (4). 540-543 (Pubitemid 37025376)
43. Fronczek R, Overeem S, Lee SY, et al. Hypocretin (orexin) loss in Parkinson's disease.. Brain. 2007 ; 130 (pt 6). 1577-1585 (Pubitemid 47355929)
44. Lessig S, Ubhi K, Galasko D, et al. Reduced hypocretin (orexin) levels in dementia with Lewy bodies. Neuroreport. 2010 ; 21 (11). 756-760
45. Wu YH, Fischer DF, Kalsbeek A, et al. Pineal clock gene oscillation is disturbed in Alzheimer's disease, due to functional disconnection from the "master clock". FASEB J. 2006 ; 20 (11). 1874-1876
46. Gerashchenko D, Murillo-Rodriguez E, Lin L, et al. Relationship between CSF hypocretin levels and hypocretin neuronal loss. Exp Neurol. 2003 ; 184 (2). 1010-1016 (Pubitemid 38182831)
47. Higuchi S, Usui A, Murasaki M, et al. Plasma orexin-A is lower in patients with narcolepsy. Neurosci Lett. 2002 ; 318 (2). 61-64 (Pubitemid 34127687)
48. Dalal MA, Schuld A, Haack M, et al. Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients. Neurology. 2001 ; 56 (12). 1749-1751 (Pubitemid 32574579)